Corporate Giving

Funding and support

Beyond developing new therapies for those in need, GBT is committed to collaborating with patients, advocacy groups, healthcare professionals (HCPs) and researchers. We do this through grants, charitable contributions, sponsorships and research opportunities.

GBT Community Fund

As a result of the COVID-19 pandemic, the sickle cell disease (SCD) community is in a time of crisis, as many patients and family members struggle to access critical services and require help to meet their basic needs, including food, water, protective gear, basic supplies, mental health, educational and other support services. The GBT Community Fund provided $150,000 in grants to support the acute needs of SCD patients and families during the COVID-19 pandemic.

Visit the COVID-19 Information and Resources page for more information about GBT’s response to the pandemic.

Community Engagement & Partnership

Community is our strength and inspiration. Since the beginning, we have collaborated closely with the sickle cell community to make a difference in patient care for those with SCD and other grievous blood-based disorders. We continue to work closely with patient advocacy groups, community-based organizations, SCD treatment centers and key government stakeholders to support innovative programs, education and awareness activities.

Medical Affairs

GBT collaborates with researchers, physicians, public health experts and others who share our passion for creating medicines for SCD. We sponsor research conducted by external scientists with the goal of advancing scientific knowledge and patient care within our clinical areas of interest. We also support continuing medical education and educational initiatives aimed at healthcare professionals.

How we’re committed to ACCELerating progress

We are particularly proud of our Access to Excellent Care for Sickle Cell Patients (ACCEL) Program, which provides grant funding designed to accelerate the development of sustainable access to care programs for people with SCD. These grants are available to help community-based organizations (CBOs) and institutions create programs that make it easier for patients to get SCD care and ensure that providers deliver the highest quality care possible. Over time, these programs will have the potential to dramatically improve access to high-quality, comprehensive healthcare for people with SCD.

In 2021, GBT expanded the priority areas for the ACCEL Program to include initiatives that address the impact of race and healthcare disparities and COVID-19 vaccine awareness among the SCD community. The program will fund 10 proposals from U.S.-based CBOs and institutions, providing a grant of up to $50,000 each, during a 12-month period.

Suggested access-to-care programs may include, but are not limited to:


  • Educational initiatives that empower SCD patients and enable them to navigate the healthcare system
  • Educational programs which target Healthcare Provider education around the impact of race and healthcare disparities
  • Improving transition from pediatric to adult care
  • Initiatives around COVID-19 vaccine awareness for SCD patients
  • Community outreach models using community health workers to directly facilitate access to care


  • Innovative training programs
  • Improving transition from pediatric to adult care
  • Innovative outreach models
  • Educational programs focused on the impact of race and healthcare disparities
  • Educational initiatives focused on patient empowerment and shared decision making
  • Initiatives around COVID-19 vaccine awareness for SCD patients